Bacterial Endotoxin Activity in Human Serum Is Associated With Dyslipidemia, Insulin Resistance, Obesity, and Chronic Inflammation

TLDR: In this paper, the authors investigated whether bacterial lipopolysaccharide (LPS) activity in human serum is associated with the components of the metabolic syndrome (MetS) in type 1 diabetic patients with various degrees of kidney disease and patients with IgA glomerulonephritis (IgAGN).

Abstract: OBJECTIVE To investigate whether bacterial lipopolysaccharide (LPS) activity in human serum is associated with the components of the metabolic syndrome (MetS) in type 1 diabetic patients with various degrees of kidney disease and patients with IgA glomerulonephritis (IgAGN) RESEARCH DESIGN AND METHODS Serum LPS activity was determined with the Limulus Amoebocyte Lysate chromogenic end point assay in type 1 diabetic patients with a normal albumin excretion rate ( n = 587), microalbuminuria ( n = 144), macroalbuminuria ( n = 173); patients with IgAGN ( n = 98); and in nondiabetic control subjects ( n = 345) The relationships of the LPS/HDL ratio and MetS-associated variables were evaluated with Pearson correlation RESULTS The MetS was more prevalent in type 1 diabetic patients (48%) than in patients with IgAGN (15%) Diabetic patients with macroalbuminuria had a significantly higher serum LPS/HDL ratio than patients with IgAGN In the normoalbuminuric type 1 diabetic group, patients in the highest LPS/HDL quartile were diagnosed as having the MetS three times more frequently than patients in the lowest quartile (69 vs 22%; P CONCLUSIONS High serum LPS activity is strongly associated with the components of the MetS Diabetic patients with kidney disease seem to be more susceptible to metabolic endotoxemia than patients with IgAGN Bacterial endotoxins may thus play an important role in the development of the metabolic and vascular abnormalities commonly seen in obesity and diabetes-related diseases